199800 Stock Chart & Stats
₩38800.00
-₩3,600.00(-8.49%)
―
--
Day’s Range― - ―
52-Week Range₩26,650.00 - ₩142,000.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)41.67K
Market Cap
₩381.39B
Enterprise ValueN/A
Total Cash (Recent Filing)₩40.77B
Total Debt (Recent Filing)₩14.43B
Price to Earnings (P/E)―
Beta0.75
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1075.97
Shares Outstanding8,997,629
10 Day Avg. Volume34,033
30 Day Avg. Volume41,673
Financial Highlights & Ratios
PEG Ratio-0.84
Price to Book (P/B)10.22
Price to Sales (P/S)670.12
P/FCF Ratio-35.14
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
199800 FAQ
What was ToolGen Incorporated’s price range in the past 12 months?
ToolGen Incorporated lowest stock price was ₩26650.00 and its highest was ₩142000.00 in the past 12 months.
What is ToolGen Incorporated’s market cap?
ToolGen Incorporated’s market cap is ₩381.39B.
When is ToolGen Incorporated’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were ToolGen Incorporated’s earnings last quarter?
ToolGen Incorporated released its earnings results on May 14, 2026. The company reported -₩491.041 earnings per share for the quarter, missing the consensus estimate of N/A by -₩491.041.
Is ToolGen Incorporated overvalued?
According to Wall Street analysts ToolGen Incorporated’s price is currently Undervalued.
Does ToolGen Incorporated pay dividends?
ToolGen Incorporated does not currently pay dividends.
What is ToolGen Incorporated’s EPS estimate?
ToolGen Incorporated’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ToolGen Incorporated have?
ToolGen Incorporated has 8,997,629 shares outstanding.
What happened to ToolGen Incorporated’s price movement after its last earnings report?
ToolGen Incorporated reported an EPS of -₩491.041 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.055%.
Which hedge fund is a major shareholder of ToolGen Incorporated?
Currently, no hedge funds are holding shares in KR:199800
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
ToolGen Incorporated
ToolGen Inc. is a biotechnology firm dedicated to the research and development of cutting-edge genome editing technologies. The company supplies a variety of ready-to-use reagents for gene engineering experiments, including purified gRNA/Cas9, standard gRNA/Cas9, and recombinant Cas9 protein. Beyond its product offerings, ToolGen also provides specialized services such as the creation of genome-edited cell lines, genetically modified mice/rats, and altered plants, in addition to performing surrogate reporter synthesis and in-del analysis.
ORIENTBIO, Inc.
―
Pharmicell Co., Ltd
―
GeneOne Life Science, Inc.
―
Bioneer Corporation
―
Genomictree, Inc.
―